Hirsch Jamie S, Danna Samuel Colby, Desai Nihar, Gluckman Ty J, Jhamb Manisha, Newlin Kim, Pellechio Bob, Elbedewe Ahlam, Norfolk Evan
Northwell Health, Northwell Health Physician Partners, 100 Community Drive, Floor 2, Great Neck, NY 11021, USA.
VA Southeast Louisiana Healthcare System, 2400 Canal Street, New Orleans, LA 70119, USA.
J Clin Med. 2024 Feb 20;13(5):1206. doi: 10.3390/jcm13051206.
Approximately 37 million individuals in the United States (US) have chronic kidney disease (CKD). Patients with CKD have a substantial morbidity and mortality, which contributes to a huge economic burden to the healthcare system. A limited number of clinical pathways or defined workflows exist for CKD care delivery in the US, primarily due to a lower prioritization of CKD care within health systems compared with other areas (e.g., cardiovascular disease [CVD], cancer screening). CKD is a public health crisis and by the year 2040, CKD will become the fifth leading cause of years of life lost. It is therefore critical to address these challenges to improve outcomes in patients with CKD.
The CKD Leaders Network conducted a virtual, 3 h, multidisciplinary roundtable discussion with eight subject-matter experts to better understand key factors impacting CKD care delivery and barriers across the US. A premeeting survey identified topics for discussion covering the screening, diagnosis, risk stratification, and management of CKD across the care continuum. Findings from this roundtable are summarized and presented herein.
Universal challenges exist across health systems, including a lack of awareness amongst providers and patients, constrained care team bandwidth, inadequate financial incentives for early CKD identification, non-standardized diagnostic classification and triage processes, and non-centralized patient information. Proposed solutions include highlighting immediate and long-term financial implications linked with failure to identify and address at-risk individuals, identifying and managing early-stage CKD, enhancing efforts to support guideline-based education for providers and patients, and capitalizing on next-generation solutions.
Payers and other industry stakeholders have opportunities to contribute to optimal CKD care delivery. Beyond addressing the inadequacies that currently exist, actionable tactics can be implemented into clinical practice to improve clinical outcomes in patients at risk for or diagnosed with CKD in the US.
美国约有3700万人患有慢性肾脏病(CKD)。CKD患者具有较高的发病率和死亡率,给医疗系统带来了巨大的经济负担。在美国,用于CKD护理的临床路径或明确的工作流程数量有限,这主要是因为与其他领域(如心血管疾病[CVD]、癌症筛查)相比,卫生系统对CKD护理的优先级较低。CKD是一场公共卫生危机,到2040年,CKD将成为导致寿命损失年数的第五大主要原因。因此,应对这些挑战对于改善CKD患者的治疗效果至关重要。
CKD领导者网络与八位主题专家进行了一场为期3小时的虚拟多学科圆桌讨论,以更好地了解影响美国CKD护理的关键因素和障碍。会前调查确定了涵盖CKD在整个护理过程中的筛查、诊断、风险分层和管理的讨论主题。本文总结并展示了本次圆桌会议的结果。
卫生系统普遍存在挑战,包括提供者和患者缺乏认识、护理团队带宽受限、早期CKD识别的经济激励不足、诊断分类和分诊流程不规范以及患者信息未集中化。提议的解决方案包括强调与未能识别和处理高危个体相关的近期和长期财务影响、识别和管理早期CKD、加强对提供者和患者基于指南的教育支持力度以及利用下一代解决方案。
支付方和其他行业利益相关者有机会为优化CKD护理做出贡献。除了解决当前存在的不足之外,还可以将可行的策略应用于临床实践,以改善美国有CKD风险或已被诊断为CKD的患者的临床结局。